235 related articles for article (PubMed ID: 25738991)
1. Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems.
Gao S; Xu Y; Asghar S; Chen M; Zou L; Eltayeb S; Huo M; Ping Q; Xiao Y
J Drug Target; 2015; 23(6):481-96. PubMed ID: 25738991
[TBL] [Abstract][Full Text] [Related]
2. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
[TBL] [Abstract][Full Text] [Related]
3. The compatibility of Tacrine molecule with poly(n-butylcyanoacrylate) and Chitosan as efficient carriers for drug delivery: A molecular dynamics study.
Eslami M; Nikkhah SJ; Hashemianzadeh SM; Sajadi SA
Eur J Pharm Sci; 2016 Jan; 82():79-85. PubMed ID: 26598087
[TBL] [Abstract][Full Text] [Related]
4. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad M; Khan ZA
Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin-loaded poly(butylcyanoacrylate) nanoparticles: preparation and characterization.
Liu H; Chen J
PDA J Pharm Sci Technol; 2009; 63(3):207-16. PubMed ID: 20069793
[TBL] [Abstract][Full Text] [Related]
6. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
[TBL] [Abstract][Full Text] [Related]
7. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles.
Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C
Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136
[TBL] [Abstract][Full Text] [Related]
9. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
Girotra P; Singh SK
Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
[TBL] [Abstract][Full Text] [Related]
11. In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562.
Hasandoost L; Akbarzadeh A; Attar H; Heydarinasab A
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):665-669. PubMed ID: 27133178
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin.
He W; Jiang X; Zhang ZR
J Pharm Sci; 2008 Jun; 97(6):2250-9. PubMed ID: 17853430
[TBL] [Abstract][Full Text] [Related]
13. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems.
Mitra A; Lin S
J Pharm Pharmacol; 2003 Jul; 55(7):895-902. PubMed ID: 12906746
[TBL] [Abstract][Full Text] [Related]
14. Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration.
Das D; Lin S
J Pharm Sci; 2005 Jun; 94(6):1343-53. PubMed ID: 15858853
[TBL] [Abstract][Full Text] [Related]
15. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles].
Chen RD; Ren F; Li GF; Liu SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):763-6. PubMed ID: 20423845
[TBL] [Abstract][Full Text] [Related]
17. Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy.
Zhang Y; Zhang Y; Chen J; Zhang B; Pan Y; Ren L; Zhao J; Luo Y; Zhai D; Wang S; Wang J
Nanomedicine; 2007 Jun; 3(2):144-53. PubMed ID: 17468053
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles.
Kreuter J; Ramge P; Petrov V; Hamm S; Gelperina SE; Engelhardt B; Alyautdin R; von Briesen H; Begley DJ
Pharm Res; 2003 Mar; 20(3):409-16. PubMed ID: 12669961
[TBL] [Abstract][Full Text] [Related]
19. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of polybutylcyanoacrylate magnetic nanoparticles.
Ren F; Chen JH; Jiang YD; Chen ZL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):161-3. PubMed ID: 14965816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
